XML 107 R42.htm IDEA: XBRL DOCUMENT v3.25.0.1

SHARE-BASED PAYMENTS (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Deferred Compensation Arrangement with Individual, Share-Based Payments

The Company’s share-based compensation expense, by type of award, is as follows:

			Years Ended December 31,
			2024						2023						2022
RSUs(1)			$	3,450					$	2,595					$	2,244
SARs			295						1,583						2,038
Stock options			1,669						447						359
Total share-based compensation expense(2)			$	5,414					$	4,625					$	4,641

(1)The fair value of the RSUs granted under the Compensation Plan was estimated at the date of grant using the higher of the closing share price on the NYSE American on the last trading day before the date of grant and the five-day VWAP on the NYSE American ending on the last trading day before the grant date.

(2)Share-based compensation is included in Selling, general and administration in the Consolidated Statements of Operations and Comprehensive Income (Loss).

Share-Based Payment Arrangement, Restricted Stock Unit, Activity

A summary of the Company’s unvested RSU activity is as follows:

			Number of Shares						Weighted Average Grant Date Fair Value
Unvested, December 31, 2021			900,064						$	2.94
Granted			411,467						6.52
Vested			(518,856)						2.93
Forfeited			(45,250)						5.40
Unvested, December 31, 2022			747,425						$	4.77
Granted			450,232						7.36
Vested			(448,883)						4.24
Forfeited			(106,935)						7.03
Unvested, December 31, 2023			641,839						$	6.57
Granted			879,699						6.50
Vested			(373,067)						6.20
Forfeited			(5,325)						5.59
Unvested, December 31, 2024			1,143,146						$	6.65

Share-Based Payment Arrangement, Stock Appreciation Right, Valuation Assumptions

The following table with the following weighted average assumptions used to determine fair values:

									Years Ended December 31,
									2023						2022
Risk-free interest rate									3.58		%				1.68		%
Expected life(1)									5.0 years						5.0 years
Expected volatility(2)									55.00		%				72.81		%
Expected dividend yield									—		%				—		%
Weighted average grant date fair value									$	3.45					$	3.99

(1)Monte Carlo analysis of SARs assumes employee suboptimal exercise at first vesting time for each tranche.

(2)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the SARs.

Share-based Payment Arrangement, Stock Appreciation Right, Activity

A summary of the Company’s SARs activity is as follows:

			Number of Shares						Weighted Average Exercise Price						Weighted Average Remaining Contractual Life (Years)						Intrinsic Value
Outstanding, December 31, 2021			1,672,422						$2.92
Granted			833,315						6.47
Exercised			(6,730)						2.92
Forfeited			(46,239)						5.95
Outstanding, December 31, 2022			2,452,768						$4.07
Granted			308,333						7.36
Exercised			(842,107)						2.92
Forfeited			(79,466)						7.30
Outstanding, December 31, 2023			1,839,528						$5.01
Granted			—						—
Exercised			(250,036)						2.92
Forfeited			(3,152)						7.36
Expired			(569,595)						2.94
Outstanding, December 31, 2024			1,016,745						$6.67						2.30						—
Exercisable, December 31, 2024			—						—						0.00						—

A summary of the Company’s unvested SARs activity is as follows:

			Number of Shares						Weighted Average Grant Date Fair Value
Unvested, December 31, 2021			573,549						$	1.19
Granted			833,315						3.99
Vested			—						—
Forfeited			(46,239)						4.13
Unvested, December 31, 2022			1,360,625						$	2.81
Granted			308,333						3.45
Vested			—						—
Forfeited			(79,466)						3.58
Unvested, December 31, 2023			1,589,492						$	2.89
Granted			—						—
Vested			—						—
Expired			(569,595)						1.22
Forfeited			(3,152)						3.45
Unvested, December 31, 2024			1,016,745						$	3.83

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of all stock options, including Performance-Based Options, granted under the Compensation Plan for the years ended December 31, 2024, 2023 and 2022 estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions:

			Years Ended December 31,
			2024						2023						2022
Risk-free interest rate			4.6		%				4.0		%				2.4		%
Expected life			3.1 years						3.2 years						3.2 years
Expected volatility(1)			68.2		%				74.0		%				73.2		%
Expected dividend yield			—		%				—		%				—		%
Weighted average grant date fair value			$	3.33					$	3.80					$	4.93

(1)     Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the stock options.

Schedule of share-based compensation, stock options, activity

A summary of all the Company’s stock option activity, including Performance-Based Options, is as follows:

			Range of Exercise Prices						Number of Shares						Weighted Average Exercise Price						Weighted Average Remaining Contractual Life (Years)						Intrinsic Value
Outstanding, December 31, 2021			$1.70 - $8.41						942,882						$	2.79
Granted			5.84 - 10.03						118,318						6.52
Exercised			1.70 - 5.46						(256,315)						2.93
Forfeited			3.06 - 10.03						(20,700)						5.91
Expired			1.76 - 5.18						(16,507)						2.52
Unvested, December 31, 2022			$1.70 - $8.41						767,678						$	3.24
Granted			5.34 - 8.60						153,299						7.20
Exercised			1.70 - 6.47						(348,538)						2.83
Forfeited			3.89 - 7.36						(32,250)						6.74
Expired			1.76 - 6.47						(16,720)						3.75
Outstanding, December 31, 2023			$1.76 - $8.60						523,469						$	4.48
Granted			5.09 - 8.23						772,189						7.45
Exercised			1.76 - 6.47						(122,236)						2.92
Forfeited			6.12 - 8.23						(32,637)						7.25
Expired			2.92 - 7.36						(7,813)						6.76
Outstanding, December 31, 2024			$1.76 - $8.60						1,132,972						$	6.58					3.34						$	461
Exercisable, December 31, 2024			$1.76 - $8.60						334,168						$	4.53					1.46						$	461

A summary of the Company’s unvested stock option activity is as follows:

			Number of Shares						Weighted Average Grant Date Fair Value
Unvested, December 31, 2021			213,317						$	1.34
Granted			118,318						4.93
Vested			(170,349)						1.15
Forfeited			(20,700)						4.54
Unvested, December 31, 2022			140,586						$	4.12
Granted			153,299						3.71
Vested			(92,453)						3.57
Forfeited			(32,250)						3.78
Unvested, December 31, 2023			169,182						$	4.11
Granted			772,189						3.33
Vested			(109,931)						4.29
Forfeited			(32,637)						3.61
Unvested, December 31, 2024			798,803						$	3.35

X

- Definition

Share-Based Payment Arrangement, Stock Appreciation Right, Valuation Assumptions

+ References

No definition available.

+ Details

Name:	efr_ShareBasedPaymentArrangementStockAppreciationRightValuationAssumptionsTableTextBlock
Namespace Prefix:	efr_
Data Type:	dtr-types1:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an equity-based arrangement (such as stock or unit options and stock or unit awards) with an individual employee, which is generally an employment contract between the entity and a selected officer or key employee containing a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 710
-SubTopic 10
-Name Accounting Standards Codification
-Section 30
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483043/710-10-30-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 710
-SubTopic 10
-Section 55
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482943/710-10-55-8

+ Details

Name:	us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration